Two structural proteins form the Papillomavirus (PV) capsids. While the functions of the major structural protein L1 are well established, the exact functions for the minor structural protein L2 are much less well defined, except for some information on a role in viral entry and maturation of infectious virions. To gain more insight in the function of L2 we used the yeast two hybrid system with the Human Papillomavirus (HPV) 11 L2 and HPV16 L2 as bait proteins to isolate putative cellular interaction partners. We identified four proteins interacting with L2 proteins of at least two different HPV types and this interaction was confirmed in vitro by pull-down assays. Further evidence for this interaction was obtained by in vivo localization studies. Two of the proteins, the previously described PATZ and a novel protein, designated PLINP, were localized in discrete nuclear domains and colocalized with L2. The third protein, designated PMSP, is a newly identified cytoplasmic protein which was recruited to nuclear dots when coexpressed with L2. The fourth protein interacting with HPV16, 11 and 1 L2, the tubular-nephritis antigen related protein (TIN-Ag-RP), shows a cytoplasmic as well as a membrane bound subcellular distribution. Taken together, our data indicate that L2 of HPVs with different phenotypes interacts with several cellular host proteins, recruits one of them to the nucleus, and is complexed with at least three cellular proteins in specific nuclear domains. These findings suggest an HPV type-independent modulatory function of L2 on host-cell functions that involves discrete nuclear domains and alteration of the subcellular distribution of cellular proteins. The interacting cellular proteins identified may play a role in the viral life cycle and establishment of viral persistence. © 2002 Elsevier Science (USA) 
INTRODUCTION
Human papillomaviruses (HPV) are epitheliotropic viruses found in a large number of different vertebrates. The virus life cycle is tightly connected to the differentiation program of the infected stratified epithelium and due to this fact papillomaviruses cannot be efficiently produced in vitro (Stubenrauch and Laimins, 1999) . Over one hundred different Papillomavirus types infecting humans have been identified, causing both, benign and malignant diseases (zur Hausen, 2001) . The organization of the viral genome is highly conserved between the different Papillomavirus types. Papillomaviruses possess an icosahedral capsid of a T ϭ 7 symmetry composed of the major structural protein L1 and the minor structural protein L2 in addition to the viral genome coated by cellular histones (Baker et al., 1991) . It has now been well established, that the L1 protein alone self assembles into virus-like particles (VLPs) in a number of different experimental systems. These particles bind to a receptor molecule present on the surface of many different cell types and there is no indication that different Papillomavirus types bind to different receptor molecules (Müller et al., 1995; Roden et al., 1994a) . The exact role of the viral minor structural protein L2 is, however, less clear. While 360 L1 molecules are present in a virion, it has been estimated that there are only 12 L2 molecules. It has been assumed that these L2 molecules are located in the center of the twelve pentavalent capsomers in the capsid (Trus et al., 1997) . There have been reports that L2 is required for the generation of infectious virions or pseudovirions and that L2, in addition to L1, interacts with a cell surface receptor (Kawana et al., 2001; Okun et al., 2001) . In fact, part of the L2 protein present in the virions extends to the surface of the viral particles and is a target for neutralizing antibodies. These antibodies, however, do not interfere with attachment of the virions to the cell surface (Liu et al., 1997; Roden et al., 1994b) .
In addition to a role of L2 in the entry pathway of the papillomaviruses, the L2 protein might be a key factor during assembly and maturation of the viruses. When expressed in tissue culture cells, L2 of the Bovine Papillomavirus 1 (BPV 1) can accumulate in distinct nuclear dots that have been identified as promyelocytic leukemia oncogenic domains (PML-oncogenic domains or PODs, PML bodies, ND10) (Day et al., 1998) . These nuclear domains are defined by the presence of a number of cellular proteins, the best characterized is the PML protein itself (Maul et al., 2000) . Although the exact functions of PODs in cells are yet undetermined, they appear to play an important role in several cellular processes including transcriptional regulation. The latter is evident for instance by the fact that several transcription factors are transient or permanent components of PODs (Sternsdorf et al., 1997) . Although it has yet to be determined why the L2 protein targets PODs, an involvement in the assembly process of papillomaviruses has been hypothesized in which L2 recruits other viral components such as L1 and E2 to PODs. Since the E2 protein is the only viral protein that is able to specifically recognize the viral DNA, the hypothesized assembly of PV capsids would explain how the preferential packaging of the viral DNA is accomplished.
To further elucidate L2 functions in infected cells, we performed a yeast two hybrid screening with HPV16 and HPV11 L2 as baits. We identified a number of different putative interaction partners for L2. Some of the identified cellular proteins interacted with the L2 proteins of two or three different HPV types (HPV11, HPV16, and HPV1) implicating a conserved function in the viral life cycle.
RESULTS

Identification of candidate interaction partners of HPV11 and HPV16 L2
To identify cellular proteins that interact with the HPV minor capsid protein L2 we performed yeast two hybrid screenings of a human keratinocyte cDNA library containing 2.5 ϫ 10 6 independent clones. Two independent screenings were initiated using either HPV11 L2 or HPV16 L2 as baits. Upon transformation of yeast cells with the bait and the library expression constructs in each of the two screenings, a large number of colonies on selective minimal medium (ϪH-A-L-Tϩ3AT) were obtained. Yeast colonies from these initial transformations were repeatedly plated on selective medium to confirm the His ϩ and Ade ϩ phenotype. From the candidate clones obtained with HPV11 L2 as a bait, 56 out of 85 were confirmed after 3 rounds of replating on selective media. These candidates were further assayed for strength of interaction by using a ␤-galactosidase reporter gene assay. 38 clones with potentially strong HPV L2 affinity (␤-gal activity Ͼ15 units) were found ( Fig. 1A) . Upon retesting the 38 cDNAs by retransformation in yeasts carrying either the HPV11 L2-bait vector, the empty bait vector or a bait vector encoding the retinoblastoma susceptibility protein (p107), respectively, 9 clones expressing proteins interacting with HPV11 L2 remained (Table 1 ). An analogous screening performed for HPV16 L2 interacting proteins resulted also in identification of nine cDNAs coding for candidates (Table 1 and Fig. 1B ) which fulfilled the criteria given above.
Sequence analysis of potential common and HPV type-specific L2 interaction partners
The cDNAs of the 18 prey plasmids obtained by screening with the HPV11 L2 and HPV16 L2 bait plasmid were subsequently sequenced, and a BlastN search of Genbank with the DNA sequences was performed. Thirteen of 18 clones were identified as gene products described previously, and five clones were identified as yet uncharacterized entries (' cDNA') in the Genbank library (Table 1) . Notably, several of the 18 cDNAs encoded independent clones of the same protein (Table 1) . For example, the Tip60 gene is represented by 3 independent clones (No. 553, No. 559, No. 575) interacting with HPV16 L2 in the yeast system. Furthermore, a G-protein ␤-subunit was found twice (No. 40 and No. 47) in the screening with HPV11 L2 as a bait and once in the screening using HPV16 L2 as a bait (No. 76) . These data as well as the low expression levels of these proteins in cells argue for the selectivity and specificity of our screening procedure.
In order to maximize the chance of having isolated interaction partners of HPV L2 proteins even further, we also analyzed whether any of the 18 prey proteins identified with the HPV16 or HPV11 L2 bait is able to interact with L2 from three different HPVs (HPV1, HPV11, and HPV16). These types represent the different tropism and pathogenic potential found among the human papillomaviruses. Upon transformation of the corresponding plasmids into yeast, 3 of the 18 prey plasmids (No. 10, No. 44, No. 557) tested generated colonies and were positive in the o-NPG assay, indicating that the corresponding 3 proteins interact with the L2 protein of at least 2 different papillomaviruses. Comparison of the cDNAs isolated with the L2 proteins of HPV11 and HPV16 indicates 1 potential common interacting candidate (No. 16) which did, however, not bind to HPV1 (Table 1A) . Therefore, there may be cellular proteins which bind to L2 proteins of most, if not all HPV types and others which are more selective. Given the rather high sequence divergence of L2 proteins, different pathogenic potentials, and differences in the tropism of various HPVs on the one hand and a likely common function of L2 proteins in the life cycle of all HPVs on the other hand, this is well conceivable. In the following we describe the sequence features and functional analysis of only those cellular proteins identified in the yeast two hybrid which appear to interact with at least two different L2 proteins (clones No. 10, No. 16, No. 44, No. 557) , and, therefore, are more likely to shed light on HPV type-independent functions of the L2 protein in the viral life cycle.
Two of the cDNAs (No. 10 and No. 557) code for proteins described previously. cDNA No. 10 contains the partial sequence (amino acids 160-380) of the 59 kDa PATZ protein (POZ/BTB-AT-hook-zinc finger protein) reported to be a nuclear protein with trans-repressive functions which interacts with RNF4 (RING-finger protein), a co-regulator of the androgen receptor-dependent transcription (Fedele et al., 2000) . The PATZ protein is expressed at low levels in all tissues examined so far, with particular high expression in human testis. The partial sequence of the PATZ cDNA isolated here comprises the DNA-binding AT-hook motif, two of the four zinc-finger motifs as well as both nuclear localization signals identified by Fedele et al., but is lacking the N-terminal BTB/ POZ domain, a protein-protein-interaction interface. As the RNF4 interacting clones described by Fedele et al. overlap in the region around the AT-hook, the polypeptide encoded by cDNA No. 10 might very well represent an additional protein-protein-interaction domain. Interest-ingly, Fedele et al., localized PATZ in a nuclear dot-like structure similar to the PODs, where the BPV1 L2 was found in a previous report.
cDNA No. 557 represents a partial sequence of TIN-Ag-RP (tubulointerstitial nephritis antigen related protein) (Brömme et al., 2000) , a protein of the extracellular matrix related to cathepsin B proteases. Unlike cathepsin, TIN-Ag-RP has no proteolytic activity due to a single amino acid exchange in the catalytic domain (C 3 S) and beyond that little is known about its function. The fulllength protein has a calculated molecular weight of 55 kDa. The protein is moderately expressed in almost all tissues examined, particularly in vascular smooth muscle cells and other muscle types, and no expression was detected in hematopoetic cells (Wex et al., 2001) .
cDNA No. 16 codes for a so far unknown protein with a calculated molecular weight of 25.4 kDa. Based on its interaction with both the HPV16 L2 and HPV11 L2 protein in the yeast system we propose the designation "Papil-FIG. 1. o-NPG assay: Interaction of L2 and the prey proteins in the yeast system determined by ␤-galactosidase activity. A: HPV11 L2; B: HPV16 L2. The cut-off value for strong interaction was arbitrarily set at 15 units (HPV11 L2) and 12 units (HPV16 L2) respectively. Clones interacting with both L2 proteins display a ␤-galactosidase activity similar with both L2 types except for No. 16 that activates ␤-galactosidase much stronger together with HPV16 L2 compared to HPV11 L2. Numbers are indicating clones that were positive in the back-transformation experiments and included in further analysis. At least two independent experiments were performed resulting in comparable ␤-galactosidase activities of the various clones. The error bars shown represent the standard deviation of one of the experiments using a triplicate assay setup. lomavirus L2 interacting nuclear protein" (PLINP; EMBL Database Submission AJ429498). The DNA sequence of cDNA No. 16 has a 99% identity with a 708 bp-long cDNA derived from a choriocarinoma (Genbank Accession No. BG479195) and only slightly lower sequence identity (up to almost 99%) with additional entries. The corresponding genomic sequence is located on chromosome 19p13.2 (Accession No. HSAD92). The Genbank entries reveal PLINP mRNA to be expressed ubiquitously as it was detected in normal and tumorous human tissue/ cells derived from brain, lung, skin, muscle, testis, spleen, and eyes. PLINP sequences of the mouse and rat homologue (partial sequence) are present in the databases (Accession Nos. AK019570 and AI411436). Comparative analysis revealed a high level of sequence similarity (77.5% similarity and 73.9% identity) between the human and mouse PLINP protein. No significant similarities to other proteins were found using BLASTP2 searches of databases. For the human polypeptide only low similarities for a subsequence of PLINP (in a stretch of 71-82 amino acids) to other proteins were found, among them the hypothetical protein DKFZp434A025.1 (Accession No. T46481, 35% identity), a mouse serine threonine kinase (Accession No. T30989; 35% identity) and a human translation initiation factor IF2 homologue (or hypothetical protein DKFZ p434I036.1, Accession No. T43483, 31% identity). Since the similarities were not found in defined clusters, the database analysis does not provide additional information about putative functional domains of PLINP. Analysis of the human PLINP polypeptide revealed no significant motifs or domains, except for a potential nuclear localization sequence (NLS; aa184-aa199). However, this potential NLS is absent in the rodent PLINP proteins arguing against its function or for a species-specific function.
Neither an identical nor a related peptide sequence entry has been found for cDNA No. 44 which codes for a 61 aa long protein (7.4 kDa). Also a PROSITE scan did not reveal any known protein motif or domain. This protein-interacting with at least 3 HPV subtypes-was designated PMSP Note. The proteins listed in the table were identified as potential L2 interaction partners in the yeast two hybrid system. Interactions with more than one L2 protein (HPV1, HPV11, and HPV16) are indicated as well as the identity of the clone (GenBank Accession No. of the most similar cDNA, identity of the corresponding protein and length of the polypeptide encoded by the cDNA, if possible). (Papillomavirus minor structural protein interacting protein, EMBL Database Submission AJ437509).
All four proteins expressed from the cDNA as GSTfusion proteins bind in vitro to recombinant HPV16 L2
To provide independent additional evidence for interaction between the proteins encoded by the cDNAs isolated and HPV16 L2 observed an in vitro binding assay was performed (Fig. 2) . For this, a GST pulldown experiment was performed using GST-fusion proteins of the different cDNAs and a lysate of insect cells previously infected with a recombinant baculovirus encoding the HPV16 L2 protein. The proteins eluted from the sepharose in the pulldown experiment were separated by SDS-PAGE and then analyzed by Western blotting using a HPV16 L2-specific polyclonal antiserum. As shown in Fig. 2 , the 72 kDa HPV16 L2 is specifically retained on the column loaded with the GST-fusion proteins, but not with the GST negative control. This provides further evidence for the interaction of HPVL2 with all four cellular candidate proteins.
Intracellular localization of PLINP, PATZ and Tin-Ag-RP
To determine the subcellular localization of the L2interacting proteins in mammalian cells, the cDNAs were inserted in the pEGFP-C3 expression vector. Lysates of transfected cells were analyzed by western blotting using an anti-GFP-antibody to verify that the expressed fusion proteins were of the expected sizes (data not shown). To analyze the intracellular localization of the proteins encoded by the four cDNAs 911 cells (human retina cell line) were transfected with the pEGFP-vectors expressing PLINP, PMSP, PATZ, and TIN-Ag-RP as EGFPfusion proteins (Figs. 3-5) . Similar experiments were carried out using CV1 cells (African green monkey kidney epithelial cells) and Hela cells (human cervical carcinoma cell line), however, no cell type specificity of sub-cellular localization of the L2 interacting proteins was observed in these cells.
It has been previously reported that, upon expression in cells using the Semliki Forest Virus expression system, the bovine papillomavirus type 1 L2 protein localizes in distinct nuclear domains, the PML-oncogenic domains (PODs) (Day et al., 1998) . A pattern consistent with localization of L2 to PODs was also observed when 911 cells were transfected with the UF3-HPV16-L2h construct coding for an L2 protein that was codon optimized for expression in human cells (Fig. 3E) . The EGFP-fusion proteins were coexpressed with HPV16 L2 to determine whether the subcellular localization confirms the protein-protein interaction observed in the yeast system and the pulldown experiment ( Figs. 3 and 4) .
The extracellular matrix protein TIN-Ag-RP-EGFP protein was found cytoplasmically and membrane-bound with two different distinct staining patterns (Fig. 5 ). While the majority (more than 90%) of the transfected cells demonstrated a rather homogenous cytoplasmic distribution of the exogenous TIN-Ag-RP ( Fig. 5A ), in less than ten percent of cells TIN-Ag-RP accumulated in large cytoplasmic lumps (Fig. 5B ). Co-expression of HPV16 L2 with TIN-Ag-RP did partially change the localization of both proteins. In cells containing cytoplasmic lumps of TIN-Ag-RP, L2 protein was efficiently excluded from the nucleus as considerable fractions of TIN-Ag-RP and L2 were found in these cells in a perinuclear region where both proteins colocalized. In rare occasions TIN-Ag-RP was found colocalized together with L2 in nuclear dots (Fig. 5C, one cell) . Although this unusual staining pattern of TIN-AG-RP could be a result of the protein overexpression, these results argue for L2/TIN-Ag-RP interaction in higher eukaryotic cells, however, in most of the cells L2 localized to the nucleus and TIN-Ag-RP was associated with the cellular membrane or homogenously distributed in the cytoplasm (Figs. 5A and C) . FIG. 3. Subcellular localization of PLINP and HPV16 L2. 911 cells were transfected with the EGFP-PLINP-expression vector (A-D) or histone H1-GFP-(F) and EGFP-(G) expression plasmids respectively and the HPV16 L2-expression vector pUF3-L2 (B-G). The cells were fixed two days after transfection and stained for HPV16 L2 (polyclonal rabbit-␣-HPV16 L2 serum/goat-␣-rabbit-Cy3 or goat-␣-rabbit-FITC respectively (in E)). Samples were subsequently analyzed by confocal microscopy. EGFP-PLINP (green) localizes in nuclear dots (A). After coexpression of HPV16 L2 (red) a colocalization of the two proteins can be observed (B-D). HPV16 L2 (green) is localized in nuclear dots after expression in mammalian cells (E). As controls L2 (red) was coexpressed with histone H1-GFP and EGFP (green in F ϩ G), which does not result in a colocalization of these proteins.
In contrast to the TIN-Ag-RP-EGFP fusion protein, PLINP-EGFP localized exclusively in nuclei and predominantly concentrated in dot-like structures (Fig. 3A) , indistinguishable from that seen with L2 alone (Fig. 3E ). To determine whether indeed PLINP and L2 colocalize to the same subnuclear domains, we cotransfected cells with the EGFP-PLINP and the L2 expression construct. An almost perfect colocalization of the two proteins in nuclear dots was found ( Fig. 3B-D) with virtually all EGFP-PLINP protein residing in nuclear dots and only a small portion of the PLINP-specific signal in the nucleoplasm. This finding strongly argues for an in vivo interaction of PLINP and HPV16 L2.
To demonstrate specificity of the observed colocalization and to exclude the possibility that any colocalization seen was due to the EGFP portion of the fusion protein, we cotransfected cells with HPV16 L2 and either the EGFP-expression vector construct (unfused EGFP) or a construct encoding a GFP-histone H1 fusion protein (kindly provided by A. Alonso, DKFZ Heidelberg). Neither the EGFP nor the EGFP-histone H1 protein localized alone in dot-like structures nor did they colocalize with HPV16 L2 (Fig. 3F and G) indicating the specificity of the colocalization data described above.
The cellular PATZ protein (corresponding to protein encoded by cDNA No. 10) has been previously described to localize to nuclear dots. However, it was not reported so far to which type of nuclear domain they correspond nor whether there is any relation with papillomavirus L2 proteins. Therefore, we analyzed in cells cotransfected with EGFP-PATZ and HPV16 L2 expression vectors whether these two proteins are recruited into the same domains. In fact, a high degree of colocalization of L2 and PATZ in nuclear dots was observed ( Fig. 4E and F) .
Intracellular localization of PMSP is altered by coexpression of HPV16 L2
Expression of the PMSP protein revealed an exclusive or at least predominant cytoplasmic localization in transfected 911 cells although the predicted size of PMSP-GFP would still allow passive entry into the nucleus (Fig.  4A) . Unexpectedly, upon co-expression with HPV16 L2 the cytoplasmic location of EGFP-PMSP changed dramatically, a substantial portion of the PMSP protein was recruited to nuclear dot-like structures where it colocalized with L2 ( Fig. 4B-D) suggesting the interaction of L2 and PMSP in mammalian cells.
Together, the transfection studies in higher eukaryotic cells and immunofluorescence analysis provide strong and independent additional evidence that all four cellular proteins encoded by cDNAs isolated by the yeast two hybrid-screenings interact with HPV L2 proteins and are in part even altered in their intracellular locations.
DISCUSSION
In recent years several studies suggested a role for the minor capsid protein L2 at different stages of the papillomavirus life cycle (Day et al., 1998; Kawana et al., 2001; Liu et al., 1997; Roden et al., 1994b Roden et al., , 2001 . The aim of this study was to gain more insight into this through an analysis of virus-host interaction by identifying cellular interaction factors of the L2 protein. Among the potential interacting cellular proteins isolated by yeast two hybrid screenings, we focused on those clones that were positive for interaction with L2 proteins of more than one papillomavirus type. This strategy promised to reveal functions of L2 common to different HPV types and to reduce the chance of identification of false positive interaction partners during the screening and analysis. We identified four cellular proteins which interact with L2 proteins of different HPV types in yeast. The specificity of the interactions of L2 with the proteins PLINP, PMSP, PATZ, and TIN-Ag-RP was further corroborated by their in vitro interaction with HPV16 L2. Importantly, the subcellular distribution, of these cellular proteins, expressed as GFP fusion proteins, determined in presence and absence of HPV16 L2 in higher eukaryotic cells revealed a reproducible colocalization of these proteins with L2. This strongly argues that these proteins interact with L2 also in mammalian cells.
For PATZ, a localization to nuclear dots has previously been reported, similar to that of the L2 protein (Fedele et al., 2000) . Here we have demonstrated for the first time by colocalization experiments that the dots formed by both proteins are in fact identical. This confirms that the interaction of the two proteins seen in the yeast system and in the in vitro assay can also take place in mammalian cells. PATZ, a transcriptional regulator and member of the zinc finger proteins, has been originally identified as an interactor for the androgen receptor, a nuclear hormone receptor (Fedele et al., 2000; Pero et al., 2001) . Since HPV persists in host cells and induces generation of papillomas, one might speculate that the L2-PATZ interaction plays a role in gene regulation and cell de- is mostly distributed homogenously in the cytoplasm or on the cell surface (A), but can also be found in cytoplasmic lumps (B). Homogenously distributed TIN-Ag-RP displays no overlapping with coexpressed HPV16 L2 (red in C). Cytoplasmic accumulated TIN-Ag-RP in contrast, colocalizes with HPV16 L2 in the cytoplasm (D-F). Fluorescence microscopy analysis was performed as described in Fig. 3. differentiation, which are both associated with papilloma formation.
TIN-Ag-RP is a protein of the extracellular matrix and may therefore interact with the virion-embedded L2 protein during the early phase of infection. Alternatively or in addition, the partial colocalization of recombinant EGFP-TIN-Ag-RP and L2 observed in some cells indicates that these two proteins can interact also intracellularly. If these extracellular as well as intracellular interactions take place in a natural infection process, our findings may imply that TIN-Ag-RP plays a role both in papilloma virion cell attachment and in intracellular trafficking of viral proteins or viral particles.
The yet uncharacterized protein PMSP was found in the cytoplasm when expressed as an EGFP fusion protein. In contrast, when coexpressed with HPV16 L2 the PMSP was predominantly found in the nucleus where it colocalized with L2 in nuclear dots. These observations together with the pull-down and yeast two hybrid data suggest that both proteins bind directly to each other in the cytoplasm and thus the PMSP is recruited into the nucleus with or without the help of other cellular proteins. It will be interesting to investigate why this change of subcellular localization of the cellular protein takes place and whether this modulates host cell function and/or virus infection. Elucidation of the cellular function of PMSP which is unknown so far will be essential to uncover its role for the viral life cycle. A similar reasoning applies to the PLINP protein for which there is so far no hint as to its function. However, the high sequence conservation of this protein in the various mammalian species analyzed and its expression in virtually all human tissues and organs argues for an important function of PLINP which is worth to be defined. This protein is also interesting for other reasons. First, it is almost exclusively localized in PODs or closely adjacent bodies. Second, the only potential NLS sequence found in human PLINP by sequence analysis is not functional according to experiments with PLINP deletion mutants (data not shown) and this is also corroborated by the lack of a corresponding NLS sequence in the mouse PLINP. Therefore, PLINP has either a nonconventional NLS or it is recruited to the nucleus by another cellular protein.
Ongoing mutational analysis of PLINP and identification of cellular interaction partners will differentiate between these two possibilities.
To determine whether nuclear dots formed by HPV16 L2, PLINP, PATZ and PMSP are in fact PODs, as it was demonstrated for the BPV1 L2 protein earlier, we performed colocalization studies using the PML protein as a marker for PODs. Results indicated that the four proteins do not always colocalize with PML but are frequently in close association with PODs. This may indicate a difference between L2 of bovine and human papilloma viruses. Alternatively, this may be due to differences in the cell types and experimental conditions used. This is well conceivable if one considers known differences in number, size and shape of PODs in various cells as well as the dynamic nature of the POD structure and composition. Detailed ongoing studies including electron microscopic examinations will reveal how closely and often L2 is associated with or localized in PODs and which of the known components are involved in its recruitment to specific subnuclear domains. Independent of the open questions as to the relevance of the precise localization of the proteins identified and their role for the HPV life cycle our study has uncovered novel cellular components of nuclear domains and thus contributes a research field with increasing importance in general and for virus infections in particular.
MATERIAL AND METHODS
Bacterial strains
For selection of the pACT-plasmids isolated from yeast the leucine auxotroph Escherichia coli LeuB Ϫ HB101 strain was used. Plasmid propagation was performed in E. coli DH5␣. Recombinant GST-fusion proteins were expressed in the E. coli BL21(DE3) strain.
Yeast strains
For the yeast two hybrid experiments S. cerevisiae PJ596 bearing the Gal4 promoter-dependent selectable markers HIS3, lacZ, and ADE2 was used. The maintenance of the yeast cells followed standard procedures as described in the manufacturer's yeast two hybrid screening manual (Clontech, Palo Alto, CA).
Protein expression in insect cells
Production and propagation of HPV16 L2-recombinant baculoviruses was performed in Sf9 insect cells in TNM-FH media supplemented with 10% fetal calf serum according to manufactures recommendations (Novagen, Darmstadt, Germany) . For expression of the protein 250 ml of a H5 cell suspension culture at a density of 1-2 10 6 cells/ml were infected by recombinant virus at a MOI of 2-5 for three days. The cells were maintained in serum free medium (Excell 405, JRH Bioscience, Lenexa, Kansas) at 27°C. Infected cells were harvested by centrifugation at 5000 rpm for 10 min. Pellets of a 250 ml culture were resuspended in 5 ml buffer IV (20 mM Hepes (pH 7.2); 200 mM potassium acetate; 2 mM magnesium acetat; 0.5% Tween 20; 1 mM dithiothreitol) with a protease inhibitor cocktail (Complete Roche, Mannheim, Germany) and sonicated with medium intensity. Cleared lysates were obtained after centrifugation at 10000 rpm for 15 min at 4°C. The lysates were used immediately for pull down experiments.
Mammalian cells
To analyze interaction of HPV16 L2 with cellular proteins the following mammalian cell lines were used:
HeLa (ATCC CCL-2; human cervical carcinoma cells), 911 (human retina cells (Fallaux et al., 1996) ), 293T cells (human embryonic kidney cells). Cells were maintained in DMEM/10% FCS following standard procedures. For transfection, 1 ϫ 10 6 cells per 10 cm culture dish were seeded on cover glasses and cultivated overnight. Transfection was performed overnight using a calcium phosphate precipitation protocol as described previously (Chen and Okayama, 1987) . After replacement of the medium, cells were further incubated at 37°C for 40 h after transfection.
Plasmid construction
Yeast expression vectors. For the yeast two hybrid screening HPV16 L2, HPV11 L2 or HPV1 L2 were amplified by PCR and then cloned into the pAS2-1 vector (Clontech) via NcoI and EcoRI/BamHI/SmaI sites: HPV11 L2forward: 5Ј-TTT TCT AGA CCA TGG GCC CTA GGG CAC GCA GAC GTA AAC GTG GCT CA-3Ј; HPV11 L2reverse: 5Ј-TTT GAA TTC CTG TGC TGT CGC TAG GCC GCC GCC ACA-3Ј; HPV1 L2forward: 5Ј-TTT GAA GCT TCC ATG GCC ACC ATG TAT CGC CTA CGT AGA AAA C-3Ј; HPV1 L2reverse: 5Ј-TTT GGA TCC TTA TAC ATA AGC TCT TTT ACG ACG CTT-3Ј; HPV16L2forward: 5Ј-TTT TCC ATG GGA CAC AAA CGT TCT GCA AAA CGC ACA AAA CGT GCA TC-3Ј; HPV16L2reverse: 5Ј-TTT TCC CGG GGG CAG CCA AAG AGA CAT CTG AAA AAA AAT-3Ј.
Bacterial and mammalian expression vectors. The cDNAs identified in the screenings were subsequently inserted into the pGEX-4T2 expression vector (GST fusion proteins; Amersham Pharmacia) and into the pEGFP-C3 vector (GFP-fusion proteins; Clontech). Instead of cDNA No. 557 the full length clone Tin-Ag-RP (kindly provided by T. Wex, University of Magdeburg) was inserted into pEGFP-C3. For expression of HPV16 L2 in mammalian cells a codon-optimized variant of the L2 gene inserted into the pUF3 expression vector was used (Leder et al., 2001) .
Detection of recombinant proteins
For detection of HPV16 L2 a polyclonal rabbit serum (No. 20) was used (dilution for Western-blot analysis: 1:2000, for immunofluorescence detection: 1:200). EGFP fusion proteins were detected by autofluorescence or by using a monoclonal mouse anti GFP antibody (Santa Cruz; 1:2000 in Western blot analysis). As secondary antibodies for Western-blot analysis horse radish peroxidase conjugated goat anti-rabbit-or goat anti-mouseantibodies (Sigma) were used. For immunofluorescence staining goat-anti-rabbit-Cy3, goat-anti-rabbit-FITC and goat anti-mouse-Cy3 conjugates were used (Dianova).
Yeast two-hybrid screening
Yeast cells were maintained and manipulated according to standard protocols. The yeast two hybrid screening was performed as described previously (Fields and Song, 1989 ) and according to the manufacturer's instructions (Clontech). The yeast strain PJ596 was transformed with the pAS2-1 plasmid constructs containing the HPV16 L2 or HPV11 L2 gene as baits. Transformants were selected and cultivated on minimal medium lacking tryptophane. The cells were subsequently transformed with a HaCat-cDNA expression library (Clontech) in the pACT2-plasmid. This cDNA library had a complexity of 2.5 ϫ 10 6 independent clones. After initial selection and repeated re-streaking on SD minimal medium lacking histidine, adenine, leucine, and threonine containing 4 mM 3AT (3-aminotriazole) the selected clones were further analyzed for ␤-galactosidase activity by a liquid culture o-NPG assay as described by the manufacturer. The plasmid DNA from positive clones was isolated and used to transform the E. coli LeuB-HB101 strain which allows selection for the pACT2 plasmids. The cDNA clones were isolated from bacteria growing on minimal medium containing ampicillin and lacking leucine. The plasmids were retransformed into yeast cells containing pAS2-1-HPV16 L2 or -HPV11 L2, as well as into yeast cells containing the empty pAS2-1 plasmid or a pAS2-1-p107 plasmid as negative controls. Those cDNAs that allowed growth of pAS-2-HPV L2 harboring yeast cells in minimal medium but not growth of yeast cells harboring the empty plasmid were further analyzed by DNA sequencing. Additionally, these HPV16 L2-and/or HPV11 L2-interacting clones were tested for their interaction with HPV1 L2 in the yeast system.
Expression and purification of GST-fusion proteins
The GST-cDNA fusion constructs (pGEX-4T2, Amersham Pharmacia, Freiburg, Germany) were expressed in E. coli BL21(DE3). Medium was inoculated with 1/20 volume of a fresh overnight culture and incubated at 25°C until an O.D. 600 of 0.5-0.8 was reached. After addition of 100 M IPTG (isopropylthiogalactoside) for induction of the inducible lac-promoter the bacteria were cultured for 3 h. The cultures were harvested by centrifugation and washed once with phosphate buffered saline (PBS). Pellets were resuspended in buffer IV and sonicated twice for 30 seconds at 2/3 of maximum intensity. The cleared lysate obtained after centrifugation at 10,000 rpm for 15Ј at 4°C was loaded onto a GSTrap-column (Amersham Pharmacia). After binding, the column was subsequently washed with 20 volumes of buffer IV. For elution, 5 volumes of 10 mM reduced glutathion in 50 mM Tris-Cl pH 8.5 were used. Elution was monitored by UV-Absorption. Peak fractions were analyzed on a Coomassie-Blue stained 12.5% SDS-polyacrylamide gel.
In vitro protein binding assay-GST pull down FPLC-purified GST-fusion proteins were dialyzed against buffer IV and then bound to 30 l of a 50% Glutathion-Sepharose slurry for 30 min at 4°C under moderate shaking. After washing with 3 ϫ 500 l buffer IV the beads were incubated with 40 l insect cell lysate containing the HPV16 L2 protein in 1 ml buffer IV for 2 h at 4°C. The supernatant was removed subsequently and the Sepharose beads were washed three times with 500 l buffer IV. The proteins were eluted by addition of 30 l of 2ϫ protein sample buffer (20 mM Tris-Cl pH 7.5, 6% SDS, 6% ␤-mercaptoethanol, 3.5% glycerol, 0. 1% bromephenole blue) and heating to 90°C for 5 min. The samples were separated by SDS-PAGE on 12.5% gels and then analyzed by western blotting using a polyclonal rabbit anti-HPV16 L2 antiserum.
Detection of recombinant proteins by indirect immunofluorescence
After removal of the medium, transfected cells were fixed with ice cold ethanol for 5 min, washed with PBS three times and rehydrated with PBS for 10 min. The glass cover slips with cells transfected only with expression vectors encoding for GFP-fusion proteins were embedded in 50% glycerol. For immunostaining, cells were blocked for 1 h in PBS/0.05% tween20/3% milk. The first antibodies were added for 1 h in appropriate dilution; after 3ϫ washing with PBS/0.05% tween 20 secondary, fluorescence-labeled antibodies were added for 1 h. After washing with PBS/0.05% Tween20 the cover slips were embedded in 50% glycerol. Samples were analyzed by confocal laser scanning microscopy (Leica Confocal Laser Scanning Microscope DM IRBE) using excitation wave lengths 488 nm (GFP/FITC) and 543 nm (Cy3). The channels were recorded separately and merged digitally.
Sequence analysis
DNA sequence analysis was done using the GCG-HUSAR program package (DKFZ Heidelberg).
